- Home
- / Beta Bionics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Beta Bionics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$100.3 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 05, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 672.0K | 610.0K | 179.0K | 65.1M | 100.3M |
| Cost of goods sold | 29.2M | 44.7M | |||
| Gross profit | 35.9M | 55.5M | |||
| Gross profit margin, % | 55.1% | 55.4% | |||
| General and administrative expense | 25.8M | 17.9M | 31.0M | ||
| Operating expense total | 66.0M | 81.1M | 127.2M | ||
| EBIT | (65.8M) | (45.3M) | (71.7M) | ||
| EBIT margin, % | -36784.4% | -69.5% | -71.5% | ||
| Interest income | 196.0 | 3.9M | 10.9M | ||
| Interest expense | 14.0 | ||||
| Net Income | (29.6M) | (54.8M) | (64.8M) | (54.8M) | (73.2M) |
| EPS | (65.8) | (8.6) | (1.8) |